🇺🇸 FDA
Patent

US 7754220

Methods of inhibiting secretion of follicle-stimulating hormone and testosterone

granted A61KA61K31/00A61K31/7088

Quick answer

US patent 7754220 (Methods of inhibiting secretion of follicle-stimulating hormone and testosterone) held by Takeda Pharmaceutical Company Limited expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/00, A61K31/7088, A61K38/1709, A61P